The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial

Phase 3

• Conditions: nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

• Registration Number: JPRN-UMIN000009265
• Lead Sponsor: Hiroshima University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-10
• Study Completion: 2014-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Not provided

Exclusion Criteria

1, Patients with alcoholic liver diseases. 2,Patients with viral liver diseases, autoimmune hepatitis, and primary biliary cirrhosis. 3, Paitents with pregnancy. 4, Patients who have allergy against ingredients of azithromicin. 5, Patients who have allergy against other macrolides and ketolides. 6, Patients with liver cirrhosis,liver failure including severe liver function test, hepatocellular carcinoma in the liver and other organs. 7, Patients with severe heart diseases. 8, Patients with hereditary fructose intolerance, glucose-galactose malabsorption, and sucrase-isomaltase deficiency. 9, Medical doctors decided the patients inappropriate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified